Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Blast at Sun Pharma unit in Ahmednagar

      Blast at Sun Pharma unit in Ahmednagar

      supriya kashyap kashyap31 Dec 2016 11:28 AM IST
      Sun Pharmaceutical Industries Limited has clarified with reference to the recent news item appearing in The Business Line dated December 29, 2016,...
      Sanofi sues Novo Nordisk over diabetes drugs in the US

      Sanofi sues Novo Nordisk over diabetes drugs in the US

      supriya kashyap kashyap31 Dec 2016 11:28 AM IST
      France's Sanofi has filed a lawsuit in the United States accusing Novo Nordisk of falsely claiming that Sanofi insulin drugs would no longer be...
      Merck receives demand notice from NPPA for overcharging

      Merck receives demand notice from NPPA for overcharging

      supriya kashyap kashyap31 Dec 2016 11:27 AM IST
      New Delhi : Drug firm Merck said it has received demand notice from the national drug pricing regulator NPPA, alleging overcharging on Polybion L 100...
      FDA rejects Cempras antibiotic for pneumonia shares sink

      FDA rejects Cempra's antibiotic for pneumonia shares sink

      supriya kashyap kashyap31 Dec 2016 9:27 AM IST
      Cempra Inc said the U.S. Food and Drug Administration had rejected its antibiotic for community-acquired bacterial pneumonia (CABP), citing inadequate...
      Medtronic must face revived US lawsuit over Infuse

      Medtronic must face revived US lawsuit over Infuse

      supriya kashyap kashyap30 Dec 2016 9:00 AM IST
      A federal appeals court revived a lawsuit accusing Medtronic Plc of defrauding shareholders by covering up negative side effects from its Infuse bone...
      Incentives and discounts to make health insurance universal: IRDAI

      Incentives and discounts to make health insurance universal: IRDAI

      supriya kashyap kashyap30 Dec 2016 9:00 AM IST
      New Delhi : The Insurance Regulatory and Development Authority of India (IRDAI )Chairman T S Vijayan said there is a need to incentivise people who...
      Serial testers: Indias flawed generic drug trials business

      Serial testers: India's flawed generic drug trials business

      supriya kashyap kashyap30 Dec 2016 9:00 AM IST
      Vasudeva Prakash left his job as a mechanic in Hyderabad three years ago for what he calls a more lucrative career: taking part in clinical trials on...
      Zydus Cadila acquires 6 brands from MSD

      Zydus Cadila acquires 6 brands from MSD

      supriya kashyap kashyap30 Dec 2016 9:00 AM IST
      New Delhi : Drug firm Zydus Cadila said it has acquired six brands from global pharma major MSD and its subsidiaries for an undisclosed amount.The...
      Pacemakers can get hacked warns FDA, issues guidelines

      Pacemakers can get hacked warns FDA, issues guidelines

      supriya kashyap kashyap29 Dec 2016 9:00 AM IST
      The U.S. government issued rules for addressing cyber vulnerabilities in medical devices, providing manufacturers with guidelines for fixing security...
      JAMA Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data

      JAMA Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data

      supriya kashyap kashyap29 Dec 2016 9:00 AM IST
      Bengaluru : Mylan N.V. and Biocon Ltd. announced that the results of the HERITAGE study have been published in the Journal of the American Medical...
      Shilpa Medicare raises Rs 172.42 crore

      Shilpa Medicare raises Rs 172.42 crore

      supriya kashyap kashyap29 Dec 2016 9:00 AM IST
      New Delhi : Drug firm Shilpa Medicare has raised around Rs 172.42 crore by allotting 30,25,000 shares to Mauritius-based TA FII Investors Ltd.The...
      Abbott gets US antitrust approval to buy St Jude Medical

      Abbott gets US antitrust approval to buy St Jude Medical

      supriya kashyap kashyap28 Dec 2016 12:08 PM IST
      Washington : Healthcare company Abbott Laboratories (ABT.N) has won U.S. antitrust approval for its proposed $25 billion acquisition of medical...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok